Literature DB >> 16707764

Gefitinib-sensitizing mutations in esophageal carcinoma.

Mingzhou Guo, Shuang Liu, Fengmin Lu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16707764     DOI： 10.1056/NEJMc052698

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Targeted treatments for metastatic esophageal squamous cell cancer.

Authors:  Antonia Digklia; Ioannis A Voutsadakis
Journal:  World J Gastrointest Oncol       Date:  2013-05-15

2.  Integration of targeted agents in the neo-adjuvant treatment of gastro-esophageal cancers.

Authors:  D G Power; D H Ilson
Journal:  Ther Adv Med Oncol       Date:  2009-11       Impact factor: 8.168

3.  A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer.

Authors:  Soner Altiok; Heather Mezzadra; Sanjay Jagannath; Nancy Tsottles; Michelle A Rudek; Nadia Abdallah; David Berman; Arlene Forastiere; Michael K Gibson
Journal:  Int J Oncol       Date:  2010-01       Impact factor: 5.650

4.  Epigenetic regulation of the Wnt signaling inhibitor DACT2 in human hepatocellular carcinoma.

Authors:  Xiaomei Zhang; Yunsheng Yang; Xuefeng Liu; James G Herman; Malcolm V Brock; Julien D F Licchesi; Wen Yue; Xuetao Pei; Mingzhou Guo
Journal:  Epigenetics       Date:  2013-02-28       Impact factor: 4.528

5.  Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling.

Authors:  Ultan McDermott; Sreenath V Sharma; Lori Dowell; Patricia Greninger; Clara Montagut; Jennifer Lamb; Heidi Archibald; Raul Raudales; Angela Tam; Diana Lee; S Michael Rothenberg; Jeffrey G Supko; Raffaella Sordella; Lindsey E Ulkus; A John Iafrate; Shyamala Maheswaran; Ching Ni Njauw; Hensin Tsao; Lisa Drew; Jeff H Hanke; Xiao-Jun Ma; Mark G Erlander; Nathanael S Gray; Daniel A Haber; Jeffrey Settleman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-06       Impact factor: 11.205

6.  Methylation of NRN1 is a novel synthetic lethal marker of PI3K-Akt-mTOR and ATR inhibitors in esophageal cancer.

Authors:  Wushuang Du; Aiai Gao; James G Herman; Lidong Wang; Lirong Zhang; Shunchang Jiao; Mingzhou Guo
Journal:  Cancer Sci       Date:  2021-05-16       Impact factor: 6.716

7.  Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study.

Authors:  Samuel Murray; Mattheos Bobos; Nikolaos Angouridakis; Angelos Nikolaou; Helena Linardou; Evangelia Razis; George Fountzilas
Journal:  J Oncol       Date:  2011-01-03       Impact factor: 4.375

8.  Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort.

Authors:  Somayye Taghvaei; Farzaneh Sabouni; Zarrin Minuchehr
Journal:  Front Pharmacol       Date:  2021-07-01       Impact factor: 5.810

9.  Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia.

Authors:  Behnoush Abedi-Ardekani; Nazir Ahmad Dar; Mohammad Muzaffar Mir; Showkat Ahmad Zargar; M Muqbool Lone; Ghyslaine Martel-Planche; Stéphanie Villar; Mounia Mounawar; Farrokh Saidi; Reza Malekzadeh; Pierre Hainaut
Journal:  BMC Cancer       Date:  2012-12-17       Impact factor: 4.430

10.  Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity.

Authors:  Austin M Dulak; Petar Stojanov; Shouyong Peng; Michael S Lawrence; Cameron Fox; Chip Stewart; Santhoshi Bandla; Yu Imamura; Steven E Schumacher; Erica Shefler; Aaron McKenna; Scott L Carter; Kristian Cibulskis; Andrey Sivachenko; Gordon Saksena; Douglas Voet; Alex H Ramos; Daniel Auclair; Kristin Thompson; Carrie Sougnez; Robert C Onofrio; Candace Guiducci; Rameen Beroukhim; Zhongren Zhou; Lin Lin; Jules Lin; Rishindra Reddy; Andrew Chang; Rodney Landrenau; Arjun Pennathur; Shuji Ogino; James D Luketich; Todd R Golub; Stacey B Gabriel; Eric S Lander; David G Beer; Tony E Godfrey; Gad Getz; Adam J Bass
Journal:  Nat Genet       Date:  2013-03-24       Impact factor: 38.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.